Jeffrey Miller, deputy director of the Masonic Cancer Center, and his research team have been awarded a $9 million NCI grant for his program titled “NK cells, their receptors, and cancer therapy.”
To access this subscriber-only content please log in or subscribe.
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe